Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 970 shares at $38.23 ($36K) on 2023-09-01, disclosed to the SEC on 2023-09-06.
Scheduled sale ($36k) by SVP, Chief Accounting Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.04 | 883 | $33K | 90.8% |
| 2 | $38.23 | 87 | $3K | 9.2% |
| Total | $37.15 avg | 970 | $36K | 100% |
| Filing → |
| RARE | SELL | 2026-03-03 | $37K | — | Filing → |
| RARE | SELL | 2025-12-30 | $3K | — | Filing → |
| RARE | SELL | 2025-09-19 | $2K | — | Filing → |